| abstract |
The invention describes new pharmaceutical compositions, their method of manufacture and use of these compositions to be administered as combination therapy for the treatment of cardiovascular and related disorders, in particular a combination of angiotensin II antagonists, lipid regulators (HMG CoA inhibitors), platelet aggregation inhibitors and diuretics. |